Clinical Trials Logo

Clinical Trial Summary

The objective of our study was to assess the effectiveness of our reference center since its constitution. In a retrospective cohort study, we compared the activity of our center, including the time elapsed between diagnosis and access to the center and the diagnostic delay of patients with fibrous dysplasia between two periods, 1996-2006 (before certification of our center) and 2007-2019 (after certification of our center).


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05422833
Study type Observational
Source Hospices Civils de Lyon
Contact
Status Completed
Phase
Start date January 1996
Completion date December 2019

See also
  Status Clinical Trial Phase
Completed NCT01791842 - TOCILIZUMAB IN FIBROUS DYSPLASIA OF BONE Phase 2
Completed NCT00445575 - Effect of Risedronate on Bone Morbidity in Fibrous Dysplasia of Bone Phase 2/Phase 3
Recruiting NCT06177327 - Hepato-pancreato-biliary Abnormalities in Fibrous Dysplasia of Bone/McCune Albright Syndrome
Recruiting NCT03838991 - Epigenetic Regulation in Fibrous Dysplasia of Bone: mirDYS Study. N/A
Active, not recruiting NCT05509595 - Burosumab for Fibroblast Growth Factor-23 Mediated Hypophosphatemia in Fibrous Dysplasia Phase 2